With its blend of expertise, technology, global reach, & forward momentum, G&L scientific is helping define the future of regulatory excellence
Yachna Suri, VP - Regional Lead APAC
India’s pharmaceutical landscape is undergoing one of the most dynamic transformations in its history. As global companies expand development footprints and establish sophisticated Global Capability Centres (GCCs), the demand for smarter, integrated, technology-powered regulatory solutions is at an all-time high. Amid this shift, G&L Scientific is recognized not only for technical capability but for its unique ability to transform regulatory operations into strategic enablers of innovation and market access. This recognition is the outcome of a clear vision: to be the most trusted regulatory partner for the world’s leading pharmaceutical and biotech organizations, where regulatory strategy, digital capability, and global expertise operate in perfect harmony.
A Sector in Transformation
The pharmaceutical consulting landscape is evolving rapidly, driven by digitalization and the increasing need for end-to-end regulatory support. AI, data analytics, and advanced automation now influence decisions from clinical trial design to global submissions. Organizations are pursuing faster pathways, simplified compliance, and greater multi-market alignment, shifting the role of regulatory consultancies toward strategic co-leadership.
Regulatory operations are no longer just about compliance; they are about accelerating innovation, enabling smarter decisions, and navigating complexity with confidence and speed. Those who seamlessly combine domain expertise with digital transformation capability are set to lead the next era of growth.
Where G&L Scientific Stands Apart
G&L Scientific has built a differentiated model aligned to the evolving regulatory needs of globally integrated pharma, particularly those expanding operational capability through GCCs in India. As outsourcing models mature, organizations are seeking strategic partners who can drive transformation and accelerate market access. G&L supports clients with post-merger integration, data migration, regulatory system modernization, affiliate management, and large-scale operational transitions.
Whether guiding marketing authorization transfers, managing RIMS migrations, or supporting affiliates on the ground, G&L provides a trusted regulatory backbone, enabling clients to maintain continuity while advancing transformation initiatives.
A Global network with Deep, Multi-domain Expertise
G&L Scientific’s strength lies in its ability to deploy regulatory expertise across major global markets and therapeutic categories. With deep experience across pharmaceuticals, biologics, medical devices, and increasingly, advanced modalities such as cell and gene therapies, G&L supports clients throughout the product lifecycle and market expansion strategies. The company is also rapidly expanding across the Asia-Pacific region, strengthening its presence in Japan, China, South Korea, and key growth markets. Through its APAC hubs, G&L supports bidirectional regulatory expansion, enabling Asian innovators to enter the US and Europe, and helping Western organizations scale into high-volume Asian markets. This combination of globally aligned strategy and locally optimized execution enables faster submissions, smoother approvals, and sustained compliance, with first-time-right delivery as a core operating principle. Global expertise, local execution, and digital innovation come together to create a seamless partnership.
With its blend of expertise, technology, global reach, & forward momentum, G&L scientific is helping define the future of regulatory excellence Yachna Suri, VP - Regional Lead APAC
Staying Ahead through Knowledge & Training
Regulatory intelligence is central to G&L’s delivery model. While the industry shifts toward AI-based monitoring, G&L maintains that expert interpretation remains essential where nuance determines success. A sophisticated internal intelligence platform aggregates updates from 100+ Health Authorities, reinforced by Lessons Learned workshops and region-specific expert forums. This ensures that consultants remain aligned with the evolving regulatory intent, not just the evolving regulatory text. Even in an age of automation, G&L places the human element at the centre of accuracy and insight.
Digital Enablement meets Domain Expertise
Technology acts as a powerful accelerator within G&L’s delivery model. Digital solutions are designed to solve real client challenges, not add complexity.
G&L brings a practical, problem-solving approach to modernizing processes, improving efficiency, strengthening visibility, and enhancing regulatory control.
The Road Ahead: A Low-risk GCC Alternative for Clients
G&L’s forward strategy spans three key dimensions:
• Deepening scientific specialization - Focused investments in emerging areas including ATMPs and Cell & Gene Therapies.
• Being a scalable GCC-alternative - By enhancing its Functional Service Outsourcing (FSO) model, G&L can operate as a ready-built, low-risk GCC, especially valuable for small and mid-sized pharma seeking operational scalability without the complexity, capital, and oversight required to establish a captive capability centre.
• Advancing predictive regulatory intelligence - Strengthening proactive strategy to accelerate timelines, reduce friction, and protect asset value.
A Partner for the Future of Global Pharma
As the pharmaceutical industry advances, the expectations of regulatory partnership are evolving with it. With its blend of expertise, technology, global reach, and forward momentum, G&L Scientific is helping define the future of regulatory excellence. Its story continues to unfold, but one truth is clear: G&L Scientific is not simply keeping pace with change. It is helping create it.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")